Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for moderate to severe insomnia
ACTRN12620000070932Phase 2Completed
- Sponsor
- Swinburne University of Technology
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in Insomnia, sponsored by Swinburne University of Technology. Started Mar 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
Insomnia
Beyond the preview
Go deeper on ACTRN12620000070932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000070932.